摘要
目的：探讨幽门螺杆菌（H p）相关性慢性胃炎诊疗效果。方法：选取2012年6月至2013年5月我院收治的H p相关性慢性胃炎患者78例进行分析，按照治疗方法分成观察组和对照组各39例，观察组采用阿莫西林、克拉霉素、雷贝拉唑和果胶铋四联疗法治疗，对照组采用阿莫西林、克拉霉素和雷贝拉唑三联疗法治疗，观察两组临床疗效、Hp清除率和不良反应发生情况。结果：观察组治疗总有效率明显高于对照组（P＜0.05），Hp清除率明显高于对照组（P＜0.05）；两组在不良反应发生率上无明显差异（P＞0.05）。结论：采用四联疗法治疗Hp相关性慢性胃炎，能够有效清除Hp，提高患者的疗效。
Abstract
Objective: Helicobacter pylori (Hp)-related chronic gastritis treatment effect. Methods: June 2012 to May 2013 in our hospital-related chronic gastritis Hp 78 patients were analyzed according to the treatment methods into observation group and control group 39 cases, the observation group amoxicil in, clarithromycin , rabeprazole and bismuth pectin quadruple therapy, the control group, amoxicil in, clarithromycin and rabeprazole triple therapy, clinical efficacy, Hp clearance rate and the incidence of adverse reactions. Results: The total effective rate was significantly higher (P <0.05), Hp clearance rate was significantly higher (P <0.05); There was no significant difference (P> 0.05) in the incidence of adverse reactions. Conclusion: Hp quadruple therapy-related chronic gastritis, can effectively remove Hp, improve patient outcomes.
NETL
NSTL
万方数据